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Pathogen multiplication rate is theoretically an important determinant of virulence, although
often poorly understood and difficult to measure accurately. We show intrinsic asexual blood
stage multiplication rate variation of the major human malaria parasite Plasmodium falciparum
to be associated with blood-stage infection intensity in patients. A panel of clinical isolates
from a highly endemic West African population was analysed repeatedly during five months
of continuous laboratory culture, showing a range of exponential multiplication rates at all
timepoints tested, mean rates increasing over time. All isolates had different genome
sequences, many containing within-isolate diversity that decreased over time in culture, but
increases in multiplication rates were not primarily attributable to genomic selection. New
mutants, including premature stop codons emerging in a few isolates, did not attain suffi-
ciently high frequencies to substantially affect overall multiplication rates. Significantly,
multiplication rate variation among the isolates at each of the assayed culture timepoints
robustly correlated with parasite levels seen in patients at clinical presentation, indicating
innate parasite control of multiplication rate that contributes to virulence.
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It is vital to understand blood-stage multiplication rates ofPlasmodium falciparum, as this single malaria parasite speciescauses more human mortality than all other eukaryotic
pathogen species combined1. It adapted specifically to humans
over the past several thousand years, after having been derived as
a spill-over zoonosis from an ancestral parasite species infecting
gorillas2. Clinical severity of P. falciparum malaria is correlated
with overall numbers of parasites in the blood3,4, and appears to
be related to multiplication rates of parasites in patients as esti-
mated by modelling5.
The first estimates of P. falciparum multiplication rates were
derived from induced infections of volunteers or neurosyphilis
patients subjected to pyretic ‘malariatherapy’ in different insti-
tutions between the 1920s and the 1950s6,7. A few different
parasite strains were used, variation among them being indicated
when combined data were later analysed, although methodolo-
gical differences among institutions may confound these retro-
spective comparisons6,7. Recent studies of experimental infections
in volunteers allow more accurate estimates of initial in vivo
multiplication rates, although these vary slightly depending on
the inoculation method8–12 as well as the statistical methods
applied11,13, and variation among parasites has not been focused
on given that a single strain has been mainly used (comparisons
with an unrelated strain indicated differences in one study14 but
not another15).
Assays of parasites from patients during the first ex vivo cycle
in laboratory culture have suggested substantial variation16–18. In
Thailand, higher multiplication rates were reported for P. falci-
parum from severe malaria patients than from mild malaria
patients16, but a subsequent study in Uganda indicated only a
marginal difference between severe and mild malaria18, and
samples from Mali or Kenya showed no difference between
clinical groups17. However, such assays are subject to potentially
confounding determinants, including effects on parasite viability
by host inflammatory responses or sample handling prior to
laboratory culture. More precise multiplication rate estimates can
be obtained for laboratory-adapted parasite strains or clinical
isolates after the first few weeks of culture ex vivo, using replicate
exponential growth assays in different donor erythrocytes, which
has demonstrated a wide range of multiplication rates among
eleven West African P. falciparum clinical isolates tested19. Sub-
stantial variation in multiplication rates have also been shown
among seven P. falciparum clones from Southeast Asian iso-
lates20, further indicating the likely importance of within-
population variation. Multiplication rates of four of the West
African isolates cultured for up to three months remained lower
than in older laboratory adapted control strains19, although
adaptation might occur over a longer period as novel alleles take
time to increase to high frequencies in culture21.
To investigate naturally occurring parasite multiplication rate
variation in depth, including potential changes during culture
adaption, and the relationship with original in vivo parasitaemia
in patients, a larger sample of new P. falciparum clinical isolates
from a highly endemic area were tested and whole genome
sequencing performed at different timepoints over five months of
culture. This revealed significant variation in multiplication rates
among the isolates, as well as a gradual increase in multiplication
rates and loss of within-isolate genomic diversity over time in
culture. New mutants only attained low to moderate frequencies
in the cultures, indicating that most of the variation is natural and
a large component of the change over time is due to parasite
plasticity. Significantly, at all timepoints the multiplication rates
were significantly positively correlated with levels of parasitaemia
measured in the individual patients, indicating that intrinsic
variation in parasite multiplication rate is a probable determinant
of clinical infection intensity.
Results
P. falciparum multiplication rates increase over time in cul-
ture. Twenty-four new clinical isolates were tested in exponential
multiplication rate assays initially after 25 days of continuous
laboratory culture, when parasites could be effectively assayed in
triplicate with erythrocytes from three anonymous donors rather
than in heterogeneous patient erythrocytes. At this time point,
assays were successfully performed on 18 of the isolates (Table 1,
and Supplementary Fig. S1), showing exponential multiplication
rates (per 48 h corresponding to an average asexual cycle time in
erythrocytes) of individual isolates that varied from 2.0-fold to
8.0-fold, with a mean of 4.3-fold (Fig. 1a, and Table 1).
Each of the isolates was continuously cultured for five months,
with exponential multiplication rates being tested again after
77 days (successful assay of 23 isolates), and after 153 days
(successful assay of 19 isolates) (Table 1, and Supplementary
Fig. S1). Multiplication rates increased over time in culture, with a
mean of 5.1-fold after 77 days, and 6.4-fold after 153 days of
culture (Fig. 1a, and Table 1). The multiplication rates were
significantly higher at the final time point compared with the first
(Mann-Whitney test, P= 0.0009, Fig. 1a), having increased
significantly over each of the time intervals (P= 0.026 for day
77 versus day 25, P= 0.042 for day 153 versus day 77, Fig. 1a). Of
the 15 isolates successfully assayed at both the first and the last
timepoints, all except one had a higher multiplication rate at the
end (Wilcoxon signed rank test, P= 0.0002, Fig. 1b).
Genome sequence diversity of parasites during culture adap-
tation. To test whether the increasing multiplication rates during
culture were due to selection of distinct genotypes or novel
emerging mutants, we sequenced the parasite genomes from each
of the culture timepoints at which multiplication rates were ana-
lysed (days 25, 77 and 153, genome accession numbers for all
isolates are given in Supplementary Table S1). Notably, each isolate
had a different genome sequence profile that was not closely related
to any of the others at any of the timepoints (Fig. 2a). There was
sufficient sequence read coverage to enable genome-wide analysis
of variation (among 153,420 biallelic SNPs and 164,392 short indel
polymorphisms mapped across the 14 haploid chromosomes)
within 23 isolates at the first timepoint, 24 at the second, and 20 at
the final timepoint. Some isolates retained the same distinct
genomic profile throughout, while for others there was turnover of
parasite genomic subpopulations over time (Fig. 2a).
We quantitatively analysed parasite genomic diversity within
isolates using the FWS fixation index (isolates with values greater
than 0.95 contain predominantly single genomes while lower FWS
values indicate increasingly complex mixtures). At the first
culture sample timepoint the mean FWS value was 0.70 (Fig. 2b),
indicating a high mean level of parasite genomic diversity within
isolates as seen in previous samples from malaria patients in the
same area22,23. During the subsequent culture process the overall
levels of within-isolate genomic diversity declined significantly
over time, moving towards fixation with a mean FWS value of 0.83
on day 77, and 0.92 on day 153, (Fig. 2b, and Supplementary
Table S2, Kruskal–Wallis test P= 0.005). Tracking individual
isolates, those that contained single predominant genome
sequences at the first timepoint (as indicated by high FWS values
>0.95) maintained the same single genome profiles at subsequent
timepoints (Fig. 2c, and Supplementary Table S2). In parallel, all
of the isolates that initially contained mixed genome profiles lost
some of their diversity during the culture period, as indicated by
increasing FWS values between the first and last timepoint (Fig. 2c,
Wilcoxon Signed rank test P < 0.001).
Isolates with single genome sequences at the first culture
sample timepoint had higher multiplication rates than those with
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Table 1 Plasmodium falciparum multiplication rates in Ghanaian clinical isolates tested in exponential growth assays at different
times over five months of continuous culture.
Patient isolate Age (yrs) Parasites µl−1 blood Hb level g dl−1 Multiplication rate (95% CI) per 48 h after:
Day 25 Day 77 Day 153
271 6 89,625 11.6 2.6 (2.1–3.2) 6.6 (4.8–9.1) 7.6 (5.5–10.6)
272 2 47,987 9.0 4.9 (3.8–6.5) 4.2 (3.3–5.5) 5.2 (4.6–6.1)
273 3 38,056 12.0 3.8 (2.5–5.6) 3.3 (2.6–4.2) 5.9 (4.7–7.2)
274 8 25,499 11.1 4.4 (3.3–5.7) 6.0 (4.4–8.3) 5.7 (3.5–9.1)
275 2 20,210 9.5 3.6 (2.9–4.6) 3.6 (2.9–4.4) 4.5 (3.7–5.6)
276 7 5,985 8.8 5.6 (5.2–5.9) 4.4 (3.6–5.3) 5.2 (3.8–7.2)
277 2 20,493 9.9 2.0 (1.7–2.4) 4.4 (3.3–5.8) —b
278 3 92,225 8.4 —a 6.0 (4.8–7.9) 10.5 (7.9–13.9)
279 8 37,410 11.5 —a 2.8 (2.2–3.5) —a
280 9 64,896 12.5 5.6 (3.5–9.1) 4.6 (3.6–5.6) 7.5 (6.2–9.0)
281 6 2,640 11.3 —a 5.8 (4.8–7.2) —c
282 5 20,776 9.5 3.1 (2.5–3.8) 2.8 (2.2–3.5) 4.7 (3.6–6.2)
284 4 36,936 10.6 2.5 (2.3–2.7) 3.8 (3.2–4.6) 6.0 (5.1–7.1)
285 9 11,700 13.3 3.2 (2.8–3.6) 3.6 (3.0–4.4) 5.6 (4.1–7.7)
286 7 59,304 12.0 3.6 (3.3–4.0) 6.9 (4.0–10.0) 8.7 (6.7–11.3)
287 5 74,784 12.5 —a 6.3 (4.8–7.9) 4.0 (3.4–4.8)
288 3 44,714 10.3 —a 4.2 (2.5–6.3) 6.5 (5.1–8.3)
289 9 42,512 12.4 3.8 (2.8–5.1) 5.5 (4.2–7.6) —c
290 4 14,364 11.3 —a —a 6.5 (5.4–7.8)
291 10 15,745 9.3 2.4 (2.2–2.7) 6.3 (4.4–9.6) 4.4 (3.5–5.4)
292 3 95,370 7.1 6.9 (5.5–8.7) 5.5 (3.6–8.3) 7.3 (5.4–9.9)
293 13 38,931 13.3 6.0 (4.4–8.1) 7.2 (5.0–11.0) 9.9 (6.9–14.4)
294 6 61,054 11.0 5.9 (4.3–8.2) 6.9 (5.8–8.3) 6.7 (5.4–8.3)
296 2 108,931 8.4 8.0 (6.4–10.0) 7.2(4.0–10.0) —c
All exponential growth assay data for all biological replicates are plotted in full in Supplementary Fig. S1, and numerical data for all measurements are given in Supplementary Data File S1. Confidence
intervals on the multiplication rates are derived by logistic regression fitting to exponential growth taking all experimental replicates into account for each isolate (all replicate datapoints shown in
Supplementary Fig S1 and Supplementary Data File S1). Missing data for some isolates are indicated by superscripts in the table (aassay did not meet pre-determined replicate requirements for accuracy
as outlined in Methods; bculture of one isolate was lost before the final timepoint; ccontamination of three isolates at the final timepoint was detected so data were excluded). Genome sequence
accession numbers, and genome-wide complexity measurements of isolates at all timepoints are given in Supplementary Tables S1 and S2.
Fig. 1 Parasite multiplication rates in a panel of 24 new Ghanaian P. falciparum clinical isolates over five months of continuous culture. a Exponential
multiplication rates per 48 h at the first assay timepoint (after 25 days) were successfully determined for 18 of the isolates, showing a mean multiplication
rate of 4.3-fold, with a wide range among the different isolates. Multiplication rates of the clinical isolates increased over time, with a mean of 5.1-fold after
77 days (assay of 23 isolates) and 6.4-fold after 153 days (19 isolates) (Mann–Whitney test, P= 0.0009 for day 153 versus day 25, and P= 0.015 for day
77 versus day 25, P= 0.042 for day 153 versus day 77). The exponential multiplication plots with experimental replicates for all isolates are shown in
Supplementary Fig. S1, all numerical data are given in Supplementary Data File S1, and 95% confidence intervals of the estimated multiplication rates based
on logistic regression of the experimental replicates are given in Table 1. b All except one of the 15 isolates that were tested at both the first and last
timepoints had an increased multiplication rate at the last timepoint (Wilcoxon rank sum test, P= 0.0002; dashed line of equivalence shown) although
wide variation among the isolates remained.
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multiple genome sequences (Mann–Whitney test, P= 0.035,
Supplementary Fig. S2). Similarly, at the second culture time-
point, isolates with single genome sequences had higher multi-
plication rates (P= 0.036), but by the final timepoint when most
isolates contained single predominant sequences there was no
significant difference. Notably, the amount of change in multi-
plication rate during culture was not significantly correlated with
the degree of change in parasite genomic diversity (delta FWS) for
individual isolates (Wilcoxon Signed rank test, P > 0.05 for each
interval between the timepoints tested).
Low frequency novel variants in culture including premature
stop codon mutants. We next performed a scan to detect
emerging sequence variants (including potential mutants) during
culture, focusing on six isolates that had single genome sequences
at the beginning and that had sequence data for all of the time-
points (identifiable in Fig. 2a). Throughout the culture period, no
SNP or indel variant that was absent at the beginning attained a
frequency of 20% at any timepoint in any isolate, except for
isolate 280 in which a premature stop codon nonsense mutant at
codon position 285 in the EPAC gene on chromosome 14 (locus
PF3D7_1417400) as well as a nonsynonymous mutant in a Cla-
thrin gene on chromosome 12 (PF3D7_1219100) were detected in
just over half of the reads at the final timepoint (Fig. 3a). A
different premature stop codon in the same EPAC gene (at codon
position 2049) was seen in isolate 272 in approximately 10% of
reads on day 77, but this was not detected at the final timepoint.
The EPAC gene has previously been shown to contain stop
codons in culture adapted parasites, but not in any uncultured
parasites21, and the mutants are predicted to lead to loss of
function as they are upstream of the predicted catalytic domain
(Fig. 3b). A premature stop codon mutant in an AP2 transcrip-
tion factor gene on chromosome 13 (PF3D7_1342900) was seen
in 16% of reads in isolate 271 at the final timepoint. Independent
premature stop codon mutants in this gene have been reported to
emerge in other clinical isolates during culture adaptation21. As
the frequencies of mutants were low in the cultures here, with the
exception of isolate 280 at the final timepoint, the overall mul-
tiplication rate phenotypes would not be significantly affected by
their presence.
Numbers of merozoites per schizont and counts of gametocytes
in culture. It was considered that the multiplication rate variation
might be due to varying numbers of merozoites produced in
schizonts. To explore this, counts of merozoites were performed
on mature schizonts in stage-synchronised cultures of nine of the
clinical isolates that had shown a range of multiplication rates,
using chemical treatment to prevent merozoite egress from
schizonts (Supplementary Fig. S3). Mean numbers of merozoites
per schizont ranged from 16.5 (for isolate 273) to 24.2 (for isolate
Fig. 2 Parasite genome sequence profiles within P. falciparum clinical isolates analysed over time in culture. a Matrix of pairwise comparisons indicates
the degree of identity between genomic profiles of parasites at different times in culture. The identity index is calculated from the within-sample allele
frequencies of 40,000 high-quality SNPs distributed throughout the 14 chromosomes of the parasite genome. Axes are labelled with the parasite isolate
identifiers and the sequential cultured timepoints having different shaded blue dots. As expected, all isolates were different from each other throughout,
and some had genomic profiles that remained the same over time while others showed some changes during culture. Sequence accession numbers for all
sample timepoints are given in Supplementary Table S1, and genome-wide sequence coverage data are given in Supplementary Table S2. b Genomic
diversity gradually reduced over time in isolates that initially had mixed genotypes. The within isolate genome-wide fixation index FWS is plotted for each
timepoint. Low values of FWS indicate isolates with a high level of genomic diversity, and values closer to 1.0 indicate where there is little within-isolate
diversity (the dotted line indicates FWS= 0.95 as values above this indicate isolates with a predominant single genotype). Mean values are shown with
horizontal bars (0.70 at day 25, 0.83 on day 77, 0.92 on day 153). The FWS values for all isolates at all timepoints are given in Supplementary Table S2.
c Comparisons between the first and last timepoints for individual isolates show that single genotype isolates remained unmixed, while all isolates that
were mixed at the beginning became less mixed (increased FWS values) by the end of the culture period.
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293). This range of ~ 1.5-fold is notable, although it is much
lower than the multiplication rate variation at any timepoint, and
correlation with multiplication rates of these isolates was not
significant (Spearman’s rho= 0.46, P= 0.20, Supplementary
Fig. S3). While numbers of merozoites produced in schizonts
could contribute to multiplication rate variation, these measure-
ments indicate that they do not explain most of the variation, and
that other cellular processes must be involved.
Differential counting of parasite stages was performed
throughout the culture period, showing that a small minority of
parasites were gametocytes. Gametocyte production in P.
falciparum usually occurs at low rates that could have a minor
effect on multiplication rates, so correlations were explored, and
the proportions of gametocytes compared with all parasite stages
observed during two-week periods surrounding the times of the
multiplication rate assays are shown in Supplementary Table S3.
For any isolate, the proportion of parasites that were gametocytes
was never in excess of 10%, the mean across all isolates being 5%
for the period corresponding to day 25, 2% for day 77, and 1% for
day 153. Across all isolates, there was no significant correlation
between proportions of gametocytes in the continuous culture
and the multiplication rates in the exponential growth assays
(non-significant trends showed varied direction among the
timepoints: for day 25, Spearman’s rho=−0.42, P= 0.08; for
day 77, Spearman’s rho= 0.16, P= 0.47; for day 153, Spearman’s
rho= 0.44, P= 0.06). It is therefore clear that the significant
multiplication rate variation described here is not caused by
gametocyte production.
P. falciparum multiplication rates correlate with levels of
parasitaemia in patients. The parasite multiplication rates in
culture were significantly and consistently positively correlated
with parasitaemia levels measured in the blood of patients at
clinical presentation (Fig. 4, and Table 1). The correlation with
patient parasitaemia that was clear in univariate analysis (Fig. 4a)
was more significant in multivariate analysis that adjusted for
patient age and haemoglobin levels, in analysis of each of the
culture time points tested separately (P= 0.013 on day 25, P=
0.003 on day 77, P= 0.008 on day 153) (Fig. 4b and Supple-
mentary Table S4). The same multivariate analysis showed that
multiplication rates were negatively but non-significantly corre-
lated with patient haemoglobin levels, and slightly positively
correlated with age (only marginally significant for one of the
timepoints, Fig. 4b and Supplementary Table S4). This indicates
that parasite multiplication rate contains a strong component of
natural variation maintained over time in culture, and that this
intrinsic parasite variation is a determinant of the density attained
in the blood of patients.
Discussion
These findings support a hypothesis that P. falciparum multi-
plication rate variation is an important virulence determinant,
directly affecting the intensity of blood stage infections4,16. The
significance of correlations between parasite multiplication rates
in culture and peripheral blood parasitaemia in patients is nota-
ble, as effective parasite multiplication in vivo will also be limited
by acquired immune responses24,25, and total parasite load is
sometimes only loosely correlated with peripheral blood para-
sitaemia due to sequestration of some developmental stages away
from circulation3. Importantly, the wide variation in multi-
plication rates described here is not explainable by parasites
having variable rates of switching from asexual replication to
sexual differentiation for mosquito transmission. Almost all P.
falciparum isolates show gametocyte conversion rates to be less
than 5% per cycle, within Ghana and elsewhere26, and there was
no significant correlation between the multiplication rates and
proportions of gametocytes at any timepoint in this study.
The mechanisms of multiplication rate variation remain to be
determined, and might involve more than one phase of the
replicative cycle. The mean numbers of merozoites within mature
schizonts varied ~1.5 fold (from approximately 16 to 24) among
isolates we measured. This range is insufficient to explain most of
Fig. 3 Selection of novel SNPs during culture adaptation of single-genotype P. falciparum clinical isolate lines. a Allele frequencies at each sampled time
point were determined by alternative sequence read counts for each variant SNP or short indel within each isolate. Novel alleles not detectable at the first
time point are plotted, with coloured dashed lines representing nonsense mutants causing premature stop codons, and grey shading representing variant
calls that do not affect the integrity of coding sequences. Isolate line 271 had a nonsense mutant in an AP2 gene (locus PF3D7_1342900) detectable by the
final timepoint. Line 272 had a nonsense mutant in the EPAC gene (locus PF3D7_1417400) detected at low frequency, while line 280 had another mutant in
the EPAC gene detected at higher frequency by the final timepoint. b Gene models with an arrow indicating the mutation position in the AP2 and EPAC
genes for each emerging nonsense SNP identified in panel A. Green boxes indicate predicted catalytic and AP2 domains. The numbers of codons in each
gene are indicated underneath each scheme (full information on each gene may be accessed on the PlasmoDB browser www.plasmodb.org46).
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the variation in multiplication rates, and no significant correla-
tion was shown here, but it could plausibly contribute a minor
component of the variation and deserves future attention
although other phases of the cycle may have a greater effect. The
typical multiplication cycle length is considered to be 48 h, and
this period was used as the nominal generation time for the
standardised analysis of multiplication here, but actual duration
of multiplication cycles have been shown to vary among several
cultured clones by up to 1.5 fold27,28, so it would be interesting to
investigate this parameter in clinical isolates. It is also possible
that transcriptome analyses might identify genes that regulate
mechanistic differences. By sampling multiple biological repli-
cates of isolates to ensure robust comparisons, analysis of mature
schizont transcriptomes has highlighted some genes with tran-
script levels that differ between long-term laboratory lines and
clinical isolates, and other genes with levels that vary among
individual clinical isolates29, but larger numbers of isolates would
be recommended in order to scan for phenotypic associations.
Analyses of all phases of the multiplication cycle in large numbers
of clinical isolates will be challenging, although it will be an
important long-term target for scaled-up single-cell tran-
scriptome approaches30.
The observation that parasite multiplication rates did not
correlate positively with levels of genomic diversity within isolates
suggests that multiplication rates are not generally accelerated in
co-infections with different genotypes, but does not entirely
exclude a possibility that multiplication rates are modified by
complex interactions in vivo within hosts having varied nutri-
tional and immune status. This study focused on parasite mul-
tiplication at cultured timepoints when biological replicates could
be effectively performed, so we analysed genome sequences at
these timepoints, but the mean level of within-isolate genomic
diversity at the first timepoint was similar to what we previously
described for other isolates sampled in the same area and
sequenced without culturing22. A hypothesis that malaria para-
sites facultatively increase their multiplication rate in response to
the presence of competing parasites has received some support
from studies of rodent malaria parasites within the blood31,
although these showed varying results. Experiments with P.
chabaudi in mice have suggested that alterations of virulence
occur during coinfections of different parasite clones32, but no
such effects of coinfection were seen in experiments with P. yoelii
in mice33. These species are distantly related to P. falciparum and
other human malaria parasites so they are not predictive models.
Nonetheless, studies of murine malaria have usefully highlighted
the potential importance of parasite plasticity in determining
virulence phenotypes34, as well as the major effects that individual
emerging mutants can have35.
Comparative genomic data indicate that P. falciparum has
adapted specifically to human hosts36,37, having been originally
derived as a zoonosis from gorillas2, and it retains a high adaptive
capacity. Notably, parasites in the first several months of culture
after clinical isolation here were only minimally affected by
mutants that are likely to become more common over longer
periods of time. This supports prioritisation of analysis of parasite
phenotypes within a limited period from original sample isola-
tion, in order to minimise effects of culture adaptation mutants.
Here, the malaria parasite multiplication rates show plasticity that
cannot be explained by genomic changes, particularly in the
isolates that each contained a single predominant genome
sequence throughout. In an earlier study, significant changes in
multiplication rates were not detected among four clinical isolates
cultured for short extended periods of up to three months19, as
this was too few isolates for a thorough analysis of variation over
time. Although the present study is much more informative, we
note that further discoveries may be possible by analysing even
larger numbers of isolates and sampling different endemic
populations.
Although they did not explain the multiplication rate variation
here, it is interesting to note that loss-of-function mutations in
particular genes appear to be selectable and are a feature of long-
term cultured parasites. Emerging mutants introducing pre-
mature stop codons in the EPAC gene (not essential for growth in
culture although it encodes a protein predicted to have cyclic
nucleotide binding sites)38 were detected in two of the six single
genotype isolates analysed, but only increased in frequency sub-
stantially in one isolate by the final timepoint. Loss-of-function
EPAC mutants were previously described in several long-term
adapted laboratory strains21, but this is the first observation of
emergence in cultured clinical isolates. As seen in one of the
isolates here, loss-of-function mutants of the transcription factor
ApiAP2 gene PF3D7_1342900 were previously observed to
Fig. 4 Parasite multiplication rates correlate significantly with levels of parasitaemia measured in patients. a Univariate significant correlation with
patient parasitaemia levels for multiplication rates assayed after 153 days of culture (earlier culture timepoints showed similar positive correlations).
b Multiple regression analysis adjusting for patient age and haemoglobin levels shows a significant positive correlation between multiplication rates and
patient parasitaemia at all culture timepoints. The coefficient on the x-axis is equivalent to the standard z-score with 95% confidence intervals. There were
non-significant residual negative correlations with haemoglobin levels, and slight positive residual correlations with age. P-values are indicated for
statistically significant correlations. Data for each of the variables in individual patients are given in Table 1, and the multiple regression coefficients are
given in Supplementary Table S4.
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emerge during culture of Gambian clinical isolates21, although the
functional consequence of these is yet to be determined. Two
other ApiAP2 genes including AP2-G that is important for
gametocytogenesis have loss-of-function mutants detected in
multiple long-term cultured laboratory clones21, so we would
predict novel mutants in these genes may eventually be seen to
emerge within clinical isolates after more extended sampling and
continuous culturing for very long periods.
This study clearly indicates intrinsic variation in P. falciparum
multiplication rates to be a determinant of natural infection inten-
sity. This should encourage efforts to identify disease risk factors by
association with parasite genome-wide variation, although the
observed parasite plasticity indicates that attention is also needed to
epigenetic regulation of transcriptional variation39, and further
experimental analyses will be required to understand mechanisms of
varying multiplication rates. Finally, adaptive multiplication rate
variation might enable parasite maintenance at low densities in
asymptomatic chronic infections, which would adversely affect
prospects for elimination or eventual eradication of malaria40.
Methods
Parasite sampling from malaria patients. Blood samples were collected from
clinical malaria cases attending Ghana government health facilities at Navrongo
(located 10°53′5″N, 1°5′25″W) in Kassena-Nankana East Municipality, in the
Upper East Region of northern Ghana in 2011. Navrongo is in the Sudan Savanah
vegetational zone in West Africa, with hyperendemic malaria transmission
dependent upon seasonal rainfall, and entomological inoculation rates were pre-
viously estimated to be a few hundred infective bites per person per year41. Patients
were eligible for recruitment into the study if they were aged 2–14 years and had
uncomplicated clinical malaria, testing positive for P. falciparum malaria by Rapid
Diagnostic Test (First Response®, Transnational Technologies, UK) and micro-
scopical examination of a Giemsa stained thick blood smear. Venous blood samples
(up to 5 ml) were collected into heparinised vacutainer tubes (BD Biosciences, CA,
USA), and a small volume was used for measurement of haemoglobin con-
centration and peripheral blood parasitaemia, the latter by counting the number of
P. falciparum parasites per 200 leukocytes on a Giemsa stained thick blood smear
and multiplying by the total leukocyte count obtained by automated haematology
analysis (all blood samples analysed in the present study had P. falciparum alone
except for isolate 290 that also contained P. malariae, a species that does not grow
in continuous culture). Half of the remaining blood sample volume was cryopre-
served in glycerolyte at −80 °C, and the other half was processed to remove leu-
kocytes before extraction of DNA from parasites in erythrocytes for whole genome
sequencing. Written informed consent was obtained from parents or other legal
guardians of all participating children, and additional assent was received from the
children themselves if they were 10 years or older. Antimalarial treatment and
other supportive care was provided according to the Ghana Health Service
guidelines. Approval for the study was granted by the Ethics committees of the
Ghana Health Service, the Noguchi Memorial Institute for Medical Research at the
University of Ghana, the Navrongo Health Research Centre and the London School
of Hygiene and Tropical Medicine.
Parasite culture. Cryopreserved patient blood samples were transferred by ship-
ment on dry ice to the London School of Hygiene and Tropical Medicine where
culture was performed. Samples were thawed from glycerolyte cryopreservation
and P. falciparum parasites were cultured continuously at 37 °C using standard
methods42 as follows (no isolates were pre-cultured before the thawing of cryo-
preserved blood in the laboratory on day 0 of the study). The average original
volume of cells in glycerolyte in each thawed vial was approximately 1 ml, which
yielded an erythrocyte pellet of at least 250 µl in all cases. Briefly, 12% NaCl (0.5
times the original volume) was added dropwise to the sample while shaking the
tube gently. This was left to stand for 5 mins, then 10 times the original volume of
1.6% NaCl was added dropwise to the sample, shaking the tube gently. After
centrifugation for 5 min at 500 g, the supernatant was removed and cells were
resuspended in the same volume of RPMI 1640 medium containing 0.5% Albu-
max™ II (Thermo Fisher Scientific, Paisley, United Kingdom). Cells were cen-
trifuged again, supernatant removed and the pellet resuspended at 3% haematocrit
in RPMI 1640 medium supplemented with 0.5% Albumax II, under an atmosphere
of 5% O2, 5% CO2, and 90% N2, with orbital shaking of flasks at 50 revolutions per
minute. Replacement of the patients’ erythrocytes in the cultures was achieved by
dilution with fresh erythrocytes from anonymous donors every few days, so that
after a few weeks of culture parasites were growing virtually exclusively in ery-
throcytes from new donors. All clinical isolates were cultured in parallel in separate
flasks at the same time, so that the donor erythrocyte sources were the same for all
the different isolates, enabling comparisons without confounding from hetero-
geneous erythrocytes.
Parasite multiplication rate assays. Exponential multiplication rate assays were
performed using a method previously described19, summarised briefly as follows.
Prior to each of the assays which were initiated after 25, 77 and 153 days of
continuous culture of the isolates, fresh blood was drawn from several anonymous
donors (anonymous volunteer staff at the London School of Hygiene and Tropical
Medicine who had not had malaria or recently taken any antimalarial drugs, and
who did not have any known haemoglobin variants), and erythrocytes were stored
at 4 °C for no more than 2 days then washed immediately before use. Each of the
assays for each isolate was performed in triplicate, with erythrocytes from three
different donors in separate flasks. Asynchronous parasite cultures were diluted to
0.02% parasitaemia within each flask at the start of each assay which was conducted
over six days. Every 48 h (day 0, 2, 4, and 6) a 300 µl sample of suspended culture
was taken (100 µl pelleted for Giemsa smear, 200 µl for DNA extraction and
qPCR), and culture media were replaced at these times.
Following extraction of DNA from the assay points, qPCR to measure numbers
of parasite genome copies was performed using a previously described protocol
targeting a highly conserved locus in the P. falciparum genome (the Pfs25 gene,
PF3D7_1031000)19. Analysis of the parasite genome numbers at days 0, 2, 4 and 6
of each assay was performed by qPCR, and quality control was performed to
exclude any assays with less than 1000 parasite genome copy numbers measured at
the end of the assay. Quality control also removed any single points where a
measurement was either lower or more than 20-fold higher than that from the
same well two days earlier in the assay, and any outlying points among the
biological triplicates that had a greater than two-fold difference from the other
replicates on the same day. Assays were retained in the final analysis if there were
duplicate or triplicate biological replicate measurements remaining after the quality
control steps, and if they showed a coefficient of determination of >0.90 for the
multiplication rate estimates using all data points from assay between days 0–4 or
days 0–6 (whichever r2 was greater indicating higher accuracy). For each assay, an
overall parasite multiplication rate (defined as per 48-h typical replicative cycle
time) was calculated with 95% confidence intervals using a standard linear model
with GraphPad PRISM. The long-term laboratory adapted P. falciparum clone 3D7
was assayed in parallel as a control in all assays, consistently showing a
multiplication rate of approximately 8.0 fold per 48 h as described previously19.
Measuring numbers of merozoites per mature schizont. Parasites were isolated
by magnetic purification using magnetic LD Separation (MACS) columns (Milte-
nyi Biotech). Each column was washed twice in 3 ml of culture medium at room
temperature. Parasite culture erythrocytes were pelleted by centrifugation at 500 g
for 5 min, then re-suspended in 3 ml culture medium per 1 ml of packed cell
volume. The re-suspended cells were bound to the MACS column, which was then
washed three times with 3 ml culture medium, and schizonts were eluted twice by
removing the magnet from the column and forcing 2 ml culture medium through
the column into a 15 ml collection tube. Finally, the schizonts were pelleted by
centrifugation at 500 g for 5 min and re-suspended in culture medium with 10 μM
E64 in a 12-well plate and incubated for 4 h at 37 °C. Giemsa stained thin blood
films were prepared for examination after this period, thus ensuring the majority of
schizonts were fully segmented for counting. A minimum of 50 schizonts were
counted for each replicate.
Genome sequencing of parasites at different timepoints in culture. DNA
extracted from parasites at each of the assayed culture timepoints was used for
whole-genome Illumina short-read sequencing. Library preparation, sequencing
and quality control was performed following internal protocols at the Wellcome
Sanger Institute, similarly to previous sequence generation from clinical isolates.
Genetic variants were called using a pipeline developed by the MalariaGEN con-
sortium (ftp://ngs.sanger.ac.uk/production/malaria/Resource/28). Briefly, short
reads were mapped with the BWA algorithm to the P. falciparum 3D7 reference
genome sequence version 3. Single Nucleotide Polymorphisms (SNPs) and short
insertions-deletions (indels) were called using GATK’s Best Practices. Variants with
a VQSLOD score <0 or outside the core genome (such as the var, rif and stevor
gene families) were excluded, resulting in 153,420 biallelic SNPs and 164,392 short
indels.
Within-isolate genomic diversity. Estimation of parasite diversity within each
isolate relative to overall local population diversity was performed using the FWS
index43,44. Allele frequencies were calculated at every SNP position for each isolate
individually, with p and q representing the proportions of read counts for the
minor and major alleles. All SNPs were then assigned to ten minor allele frequency
(MAF) intervals representing the proportional frequency of the minor allele at each
SNP across the population, with the ten equally sized intervals ranging from 0–5%
up to 45–50%. Levels of within-host (Hw) and local parasite subpopulation (Hs)
heterozygosity for each SNP were calculated as Hw= 2*pw*qw and Hs= 2*ps*qs.
The mean Hw and Hs of each MAF interval were then computed from the cor-
responding heterozygosity scores of all SNPs within that particular interval. The
resulting plot of Hw against Hs for each isolate was produced and a linear
regression model was used to determine a value for the gradient Hw/Hs, with
FWS= 1 - (Hw/Hs). All FWS analyses were performed using custom scripts in R.
COMMUNICATIONS BIOLOGY | https://doi.org/10.1038/s42003-020-01349-7 ARTICLE
COMMUNICATIONS BIOLOGY |           (2020) 3:624 | https://doi.org/10.1038/s42003-020-01349-7 | www.nature.com/commsbio 7
Emergence of new mutants. Analysis focused on isolates that each contained a
predominant single genome at the beginning (based on FWS values of >0.95), and had
data for all timepoints, following methods broadly similar to those used in analysis of
Gambian clinical isolates previously21. Allele frequencies of intragenic SNPs and
frameshift-causing indels covered by at least 10 reads were plotted for each timepoint
to scan for the emergence of new mutant alleles. The quality of the mapped sequence
reads for each of these cases were inspected visually using the Savant software45.
Statistics and reproducibility. Statistical comparisons of multiplication rates
between independent categorical groups was performed using the Mann–Whitney
test, whereas comparisons of paired sample distributions were performed using the
Wilcoxon signed-rank test. Univariate correlations were assessed using Spearman’s
rank test with the rho coefficient. Multivariate analyses adjusting for covariates
were performed using multiple regression analysis, with residual coefficients
equivalent to z-scores being expressed with 95% confidence intervals to indicate
deviation from null expectations. Any additional statistics or parameters including
those relating to the genome sequence analysis are given in the relevant sections.
All multiplication rate assays were performed using biological triplicate cultures,
with all replicate data plotted for each point in the exponential growth, and used to
estimate confidence intervals of the multiplication rate for each isolate. All qPCR
assays of each biological replicate were performed in technical duplicate, and the
mean used for estimating the parasite genome copy numbers at each point in each
assay. Counts of numbers of merozoites per schizont were performed on pre-
parations from two biological replicate cultures of each isolate and pooled for
estimating means.
Data availability
All genome sequence data have been deposited in the European Nucleotide Archive (76
accession numbers listed in Supplementary Table S1), and all SNP and indel genotypic
calls are made available ftp://ngs.sanger.ac.uk/production/malaria/Resource/28.
Supplementary Data File S1 gives all numerical data on all experimental replicates of the
exponential multiplication rate assays that are plotted in full in Supplementary Fig. S1.
Any other source data for figures and supplementary figures are available on request
from the corresponding author.
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